Mmastodon WorldWorld first seen 17 h ago, last 1 h ago, peak #1

Imaavy becomes first approved treatment for warm autoimmune hemolytic anemia

Original: Recently, Imaavy (nipocalimab-aahu) becomes the first approved treatment for warm autoimmune hemolytic anemia (wAIHA). A

Imaavy (nipocalimab-aahu) has been approved as the first-ever treatment for warm autoimmune hemolytic anemia, a rare disorder in which the immune system destroys red blood cells. Observers in the biotech and pharmaceutical community are calling it a significant win for orphan diseases, where patients have historically had no approved therapy options.

Why now: The drug marks the first regulatory approval for a previously untreatable rare disease, a milestone for orphan drug development.

Imaavynipocalimab-aahuwarm autoimmune hemolytic anemia

Open on mastodon →

Rank over time, top of the chart is #1. 19 snapshots from 17 h ago to 1 h ago.

Evidence

• Recently, Imaavy (nipocalimab-aahu) becomes the first approved treatment for warm autoimmune hemolytic anemia (wAIHA). Another win to tackle orphan diseases. https://www. reactiondigest.com/Biochemistr y/Drug-target/Imaavy # chemistry # pharmaceuticals # news # biotech #… · eronsaxon · 4

API: https://socialmediatrends-api.osmike.com/v1/trends/955074